GE announced today the shipment of the Omnyx? VL4 scanner to beta
customers worldwide. To date, six Omnyx VL4 scanners have been shipped
and are in operation for testing purposes. This marks a significant
milestone in Omnyx's efforts to deliver a leading Integrated Digital
Pathology solution. The Omnyx solution will be demonstrated at the
upcoming Pathology Visions conference in San Diego.
The Omnyx VL4 scanner was created through the joint venture of UPMC and
GE Healthcare. It is designed to resolve the tradeoff between speed and
image quality through its patented two camera technology. All scanning
operations including tissue detection and focus are automated to
minimize labor. It is tightly integrated to an enterprise software
solution that enables high-speed digital viewing over standard networks
and provides a complete digital workflow for research use for both the
pathologist and histology personnel.
George Michalopolous, Chair of Pathology at UPMC, comments, "The recent
shipment of the VL4 Scanner to UPMC allows us to further test the Omnyx
technology and make progress with our digitization plans for our
department. Whether you look at the software system or their scanning
instruments, the Omnyx team has developed an integrated product that
promises to advance pathology."
Feedback from the various beta testing sites is instrumental in
preparing the products for commercial availability.
Dr. Sylvia Asa, Chair of Pathology at University Health Network said, "I
have been impressed with the image quality of the VL4 and I have high
expectations for the Omnyx product. The Omnyx images are the best I have
seen. In addition, there were several instances when I favored the Omnyx
digital image on the monitor over the glass slide in the microscope."
So far, University Health Network (UHN) in Toronto Canada has scanned
and reviewed over 2,000 slides as part of its testing activities. The
facility started with 5 pathologists and, within 7 weeks, had 22
pathologists from nine specialty areas testing the system. This
demonstrates its intuitive ease of use and is a result of the system
having been designed by pathologists, for pathologists. Dr. Andrew Evans
will discuss UHN's preliminary experience with the Omnyx Integrated
Digital Pathology solution and the VL4 scanner at the upcoming Pathology
Visions tradeshow in San Diego.
Gene Cartwright, CEO of the Omnyx joint venture comments, "We are
grateful and thankful for the support we are receiving from our beta
sites. Great customers help us make a better product. There is no better
way of making sure we have it right than working hand-in-hand with our
customers. We expect the field of digital pathology will advance very
quickly once a complete solution is made available. The shipment of the
Omnyx VL4 scanner is a very important milestone toward that goal."
The Omnyx Integrated Digital Pathology solution is designed to integrate
into a comprehensive platform what are often stand-alone products. It
combines high speed, high quality whole slide scanning with scalable
information technology products to create a solution that addresses the
reliability and process requirements of pathologists and enables single
and multi-site organizations to benefit from increased efficiencies and
greater access to peers in the field. The Omnyx products are for
research use only and not for diagnostic use.
The Omnyx product line will include scanners, workstations, algorithms,
servers, and digital archives for storage.
By digitizing the slides and corresponding workflow, the Omnyx solution
is intended to do what a traditional microscope cannot, and improve
collaboration, communication and efficiency.
Omnyx, LLC, (www.omnyx.com)
is a joint venture of GE Healthcare and UPMC (the University of
Pittsburgh Medical Center) with locations in Pittsburgh, Pa. and
Piscataway, N.J. The company is developing an Integrated Digital
Pathology system to allow pathology departments worldwide to move to an
all-digital workflow. Their products include a family of high speed
whole-slide scanners and an enterprise software product enabling image
management, workflow automation, image analysis algorithms and system
integration. Close collaboration with pathologists at UPMC and other
institutions along with their relationship with GE Healthcare allows
Omnyx to focus its innovation on the needs of anatomic pathologists
worldwide. Omnyx products are currently in development and are for
research use only. They are not for use in diagnostic procedures.
ABOUT GE HEALTHCARE:
GE Healthcare provides transformational medical technologies and
services that are shaping a new age of patient care. Our broad expertise
in medical imaging and information technologies, medical diagnostics,
patient monitoring systems, drug discovery, biopharmaceutical
manufacturing technologies, performance improvement and performance
solutions services help our customers to deliver better care to more
people around the world at a lower cost. In addition, we partner with
healthcare leaders, striving to leverage the global policy change
necessary to implement a successful shift to sustainable healthcare
Our "healthymagination" vision for the future invites the world to join
us on our journey as we continuously develop innovations focused on
reducing costs, increasing access and improving quality around the
world. Headquartered in the United Kingdom, GE Healthcare is a unit of
General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees
are committed to serving healthcare professionals and their patients in
more than 100 countries. For more information about GE Healthcare, visit
our website at www.gehealthcare.com.
For our latest news, please visit http://newsroom.gehealthcare.com
Corey Miller, 414.469.5499